225 related articles for article (PubMed ID: 2136918)
1. Synthesis and serotonin binding site studies of some conformationally restricted indolylethylamine analogues based on 2-amino-3-(3'-indolyl)bicyclo[2.2.2]octane.
Schlecht MF; Tsarouhtsis D; Lipovac MN; Debler EA
J Med Chem; 1990 Jan; 33(1):386-94. PubMed ID: 2136918
[TBL] [Abstract][Full Text] [Related]
2. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
3. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
Naiman N; Lyon RA; Bullock AE; Rydelek LT; Titeler M; Glennon RA
J Med Chem; 1989 Jan; 32(1):253-6. PubMed ID: 2521252
[TBL] [Abstract][Full Text] [Related]
4. The 5-HT1A receptor probe [3H]8-OH-DPAT labels the 5-HT transporter in human platelets.
Ieni JR; Meyerson LR
Life Sci; 1988; 42(3):311-20. PubMed ID: 2961966
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonists.
Turconi M; Nicola M; Quintero MG; Maiocchi L; Micheletti R; Giraldo E; Donetti A
J Med Chem; 1990 Aug; 33(8):2101-8. PubMed ID: 1695682
[TBL] [Abstract][Full Text] [Related]
6. Determination of the molecular size of the 5-HT3 receptor binding site by radiation inactivation.
Gozlan H; Schechter LE; Bolanos F; Emerit MB; Miquel MC; Nielsen M; Hamon M
Eur J Pharmacol; 1989 Dec; 172(6):497-500. PubMed ID: 2533081
[TBL] [Abstract][Full Text] [Related]
7. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
Ransom RW; Asarch KB; Shih JC
J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
[TBL] [Abstract][Full Text] [Related]
8. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
Hall MD; el Mestikawy S; Emerit MB; Pichat L; Hamon M; Gozlan H
J Neurochem; 1985 Jun; 44(6):1685-96. PubMed ID: 3157780
[TBL] [Abstract][Full Text] [Related]
9. Structural factors of importance for 5-hydroxytryptaminergic activity. Conformational preferences and electrostatic potentials of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and some related agents.
Arvidsson LE; Karlén A; Norinder U; Kenne L; Sundell S; Hacksell U
J Med Chem; 1988 Jan; 31(1):212-21. PubMed ID: 2961887
[TBL] [Abstract][Full Text] [Related]
10. N,N-di-n-propylserotonin: binding at serotonin binding sites and a comparison with 8-hydroxy-2-(di-n-propylamino)tetralin.
Glennon RA; Titeler M; Lyon RA; Slusher RM
J Med Chem; 1988 Apr; 31(4):867-70. PubMed ID: 2965244
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of N,N'-bis-aminoalkyl-substituted derivatives of bicyclo[2.2.2]oct-7-ene-2,3,5,6-tetracarboxydiimide with potential anxiolytic activity.
Turło J; Zawadowski T
Farmaco; 1996 Dec; 51(12):815-8. PubMed ID: 9050215
[TBL] [Abstract][Full Text] [Related]
12. High affinity serotonin binding sites in human brain: a comparison of cerebral cortex and basal ganglia.
Cross AJ; Slater P
J Neural Transm; 1989; 76(3):211-9. PubMed ID: 2525178
[TBL] [Abstract][Full Text] [Related]
13. Modulation of 5-hydroxytryptamine1A receptor density by nonhydrolyzable GTP analogues.
Harrington MA; Peroutka SJ
J Neurochem; 1990 Jan; 54(1):294-9. PubMed ID: 2136705
[TBL] [Abstract][Full Text] [Related]
14. Characterization of 5-hydroxytryptamine 1A-like binding sites in human ganglioneuroblastoma.
Pranzatelli MR; Balletti J
Neurosci Lett; 1991 Oct; 132(1):117-20. PubMed ID: 1838579
[TBL] [Abstract][Full Text] [Related]
15. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
Mellin C; Björk L; Karlén A; Johansson AM; Sundell S; Kenne L; Nelson DL; Andén NE; Hacksell U
J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376
[TBL] [Abstract][Full Text] [Related]
16. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
18. Brain serotonin2 and serotonin1A receptors are altered in the congenitally hyperammonemic sparse fur mouse.
Robinson MB; Anegawa NJ; Gorry E; Qureshi IA; Coyle JT; Lucki I; Batshaw ML
J Neurochem; 1992 Mar; 58(3):1016-22. PubMed ID: 1531355
[TBL] [Abstract][Full Text] [Related]
19. Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups.
Monte AP; Marona-Lewicka D; Parker MA; Wainscott DB; Nelson DL; Nichols DE
J Med Chem; 1996 Jul; 39(15):2953-61. PubMed ID: 8709129
[TBL] [Abstract][Full Text] [Related]
20. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
Emerit MB; Miquel MC; Gozlan H; Hamon M
J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
